These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19661680)

  • 1. Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells.
    Kawakami Y; Kubota N; Ekuni N; Suzuki-Yamamoto T; Kimoto M; Yamashita H; Tsuji H; Yoshimoto T; Jisaka M; Tanaka J; Fujimura HF; Miwa Y; Takahashi Y
    Biosci Biotechnol Biochem; 2009 Aug; 73(8):1811-7. PubMed ID: 19661680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
    Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
    J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
    Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
    J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2.
    Jisaka M; Kim RB; Boeglin WE; Brash AR
    J Biol Chem; 2000 Jan; 275(2):1287-93. PubMed ID: 10625675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.
    Sarveswaran S; Chakraborty D; Chitale D; Sears R; Ghosh J
    J Biol Chem; 2015 Feb; 290(8):4994-5006. PubMed ID: 25540201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double dioxygenation by mouse 8S-lipoxygenase: specific formation of a potent peroxisome proliferator-activated receptor alpha agonist.
    Jisaka M; Iwanaga C; Takahashi N; Goto T; Kawada T; Yamamoto T; Ikeda I; Nishimura K; Nagaya T; Fushiki T; Yokota K
    Biochem Biophys Res Commun; 2005 Dec; 338(1):136-43. PubMed ID: 16112079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
    Tang Y; Wang MT; Chen Y; Yang D; Che M; Honn KV; Akers GD; Johnson SR; Nie D
    Int J Cancer; 2009 Apr; 124(7):1545-51. PubMed ID: 19089921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
    Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM
    Oncogene; 2005 Feb; 24(7):1174-87. PubMed ID: 15558016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and subcellular localization of two 15S-lipoxygenases in human cornea.
    Chang MS; Schneider C; Roberts RL; Shappell SB; Haselton FR; Boeglin WE; Brash AR
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):849-56. PubMed ID: 15728540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
    Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
    Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
    Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
    Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
    Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
    Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
    Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J
    Cancer Res; 2004 Jan; 64(1):209-14. PubMed ID: 14729626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.